Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
790.20
799.50
798.60
794.40
735.90
748.90
714.90
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
790.20
799.50
798.60
794.40
735.90
748.90
714.90
Raw Material Cost
103.40
100.90
87.60
92.50
75.90
83.10
77.80
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.10
3.00
7.30
6.10
7.90
10.10
11.60
Selling and Distribution Expenses
189.80
181.80
190.80
170.10
168.50
219.20
177.60
Other Expenses
13.64
12.45
12.67
14.29
12.59
9.34
12.80
Total Expenditure (Excl Depreciation)
432.70
410.20
412.40
411.60
378.20
405.80
395.00
Operating Profit (PBDIT) excl Other Income
357.5
389.3
386.2
382.8
357.70000000000005
343.1
319.9
Other Income
43.90
46.70
55.20
46.80
46.70
55.60
47.00
Operating Profit (PBDIT)
424.20
457.90
462.50
449.40
424.10
417.80
385.60
Interest
3.10
3.00
7.30
6.10
7.90
10.10
11.60
Exceptional Items
45.70
5.00
-25.70
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
686.80
698.60
711.00
701.90
660.00
665.80
637.10
Depreciation
22.80
21.90
21.10
19.80
19.70
19.10
18.70
Profit Before Tax
444.00
438.00
408.40
423.50
396.50
388.60
355.30
Tax
79.70
99.30
98.90
101.30
95.20
79.50
77.20
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
364.30
338.70
309.50
322.20
301.30
309.10
278.10
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
364.30
338.70
309.50
322.20
301.30
309.10
278.10
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
364.30
338.70
309.50
322.20
301.30
309.10
278.10
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
7,096.20
6,590.20
7,173.60
6,807.20
6,444.00
6,100.90
5,697.20
Earnings per share (EPS)
7.7
7.16
6.41
6.63
6.19
6.39
5.85
Diluted Earnings per share
7.7
7.16
6.41
6.63
6.19
6.39
5.85
Operating Profit Margin (Excl OI)
45.24%
48.69%
48.36%
48.19%
48.61%
45.81%
44.75%
Gross Profit Margin
59.07%
57.52%
53.78%
55.8%
56.56%
54.44%
52.32%
PAT Margin
46.1%
42.36%
38.76%
40.56%
40.94%
41.27%
38.9%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Dec 2025 is -1.16% vs 0.11% in Sep 2025
Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is 7.56% vs 9.43% in Sep 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Dec 2025 is -7.51% vs 0.96% in Sep 2025
Interest
QoQ Growth in quarter ended Dec 2025 is 3.33% vs -58.90% in Sep 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025
Compare Quarterly Results Of United Therapeutics Corp. With
Figures in Million
Consolidate Quarterly Results
Change(USD)
Change(%)
Net Sales
790.20
805.50
-15.30
-1.90%
Other Operating Income
0.00
0.00
0.00
Total Operating income
790.20
805.50
-15.30
-1.90%
Raw Material Cost
103.40
17.60
85.80
487.50%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
3.10
0.00
3.10
Selling and Distribution Expenses
189.80
301.80
-112.00
-37.11%
Other Expenses
13.64
25.82
-12.18
-47.17%
Total Expenditure (Excl Depreciation)
432.70
577.60
-144.90
-25.09%
Operating Profit (PBDIT) excl Other Income
357.50
227.90
129.60
56.87%
Other Income
43.90
25.80
18.10
70.16%
Operating Profit (PBDIT)
424.20
261.20
163.00
62.40%
Interest
3.10
0.00
3.10
Exceptional Items
45.70
-14.30
60.00
419.58%
Gross Profit (PBDT)
686.80
787.90
-101.10
-12.83%
Depreciation
22.80
7.50
15.30
204.00%
Profit Before Tax
444.00
239.40
204.60
85.46%
Tax
79.70
85.70
-6.00
-7.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
364.30
153.70
210.60
137.02%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
364.30
153.70
210.60
137.02%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
364.30
153.70
210.60
137.02%
Equity Capital
0
0
0.00
Face Value
0.01
0.00
0.00
Reserves
7,096.20
3,253.10
3,843.10
118.14%
Earnings per share (EPS)
7.70
1.48
6.22
420.27%
Diluted Earnings per share
7.70
1.48
6.22
420.27%
Operating Profit Margin (Excl OI)
45.24%
28.29%
0.00
16.95%
Gross Profit Margin
59.07%
30.65%
0.00
28.42%
PAT Margin
46.10%
19.08%
0.00
27.02%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 79.02 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is -1.16% vs 0.11% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 7.38% vs 19.72% in Dec 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 36.43 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is 7.56% vs 9.43% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 20.91% vs 38.78% in Dec 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 38.03 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is -7.51% vs 0.96% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 0.77% vs 37.84% in Dec 2024
Quarterly - Interest
Interest 0.31 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is 3.33% vs -58.90% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -60.76% vs -47.68% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 45.24%
in Dec 2025Figures in %
QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025
YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
